Medira GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation (NCT07536724) | Medira GmbH | 2026-05-01 |
Track Medira GmbH automatically
Every clearance here is in the API, with alerts when new ones post.